| 19.09.2023 07:00 | GSK | Apretude for PrEP receives EMA approval | RNS |
| 18.09.2023 09:40 | BPCR, FEVR, SFOR | LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS | Alliance |
| 18.09.2023 07:00 | GSK | FDA approves Ojjaara (momelotinib) | RNS |
| 15.09.2023 21:52 | GSK | GSK's Ojjaara approved in US for myelofibrosis patients with anaemia | Alliance |
| 13.09.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 11.09.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 11.09.2023 08:24 | GSK | Japan accepts GSK's regulatory filing for momelotinib for blood cancer | Alliance |
| 11.09.2023 07:00 | GSK | Momelotinib filing accepted in Japan | RNS |
| 06.09.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 06.09.2023 09:32 | CORD, ASC, AMS | LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords | Alliance |
| 04.09.2023 06:00 | GSK | More UK babies to need hospital treatment over delay of GSK's RSV jab | Alliance |
| 01.09.2023 15:00 | GSK | Total Voting Rights | RNS |
| 01.09.2023 09:11 | GSK | GSK antibody accepted for Japan review, Goldman Sachs reduces stake | Alliance |
| 01.09.2023 07:00 | GSK | GSK’s Nucala CRSwNP submission accepted in Japan | RNS |
| 31.08.2023 15:16 | GSK | Holding(s) in Company | RNS |
| 31.08.2023 15:14 | GSK | Holding(s) in Company | RNS |
| 25.08.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 23.08.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 23.08.2023 08:17 | GSK | GSK gets positive results from shingles trial of Shingrix in China | Alliance |
| 23.08.2023 07:00 | GSK | Shingrix data demonstrate 100% efficacy in China | RNS |
| 22.08.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 17.08.2023 19:53 | GSK | Charity says HIV drug deal with GSK's ViiV on ice over price secrecy | Alliance |
| 10.08.2023 15:46 | UKCM, SRE, SDR | UK dividends calendar - next 7 days | Alliance |
| 10.08.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 09.08.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 08.08.2023 13:05 | GSK | Publication of Base Prospectus | RNS |
| 07.08.2023 08:12 | GSK, HLN | PRESS: Inflexion among firms looking to buy Haleon's nicotine business | Alliance |
| 02.08.2023 20:45 | GSK | TOP NEWS: GSK sues Pfizer over patent infingements for RSV vaccine | Alliance |
| 02.08.2023 08:23 | GSK, HLN | TOP NEWS: Haleon boosts annual guidance after solid first half | Alliance |
| 01.08.2023 15:00 | GSK | Total Voting Rights | RNS |
| 31.07.2023 19:42 | GSK | IN BRIEF: GSK hails US FDA approval for cancer treatment, Jemperli | Alliance |
| 31.07.2023 18:00 | GSK | FDA approves new use for Jemperli plus chemo | RNS |
| 31.07.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 31.07.2023 12:21 | GSK, OCI, TSCO | DIRECTOR DEALINGS: Qinetiq, Tesco and GSK executives sell shares | Alliance |
| 31.07.2023 09:16 | IAG, RKT, FRAS | LONDON BROKER RATINGS: Oddo BHF raises IAG to 'outperform' | Alliance |
| 28.07.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 26.07.2023 09:28 | GSK | TOP NEWS: GSK raises annual guidance on quarterly earnings growth | Alliance |
| 26.07.2023 07:00 | GSK | 2nd Quarter Results | RNS |
| 24.07.2023 08:25 | GSK | GSK says HIV prevention drug recommended for marketing in Europe | Alliance |
| 24.07.2023 07:00 | GSK | Cabotegravir LA for PrEP receives positive CHMP | RNS |
| 20.07.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 17.07.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 14.07.2023 09:13 | SFOR, BHP, HOC | LONDON BROKER RATINGS: HSBC says 'buy' AstraZeneca but 'reduce' GSK | Alliance |
| 13.07.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 10.07.2023 09:27 | CNE, ENQ, JSE | LONDON BROKER RATINGS: HSBC downgrades commercial property stocks | Alliance |
| 06.07.2023 15:46 | YNGA, XPP, WIN | UK dividends calendar - next 7 days | Alliance |
| 05.07.2023 09:34 | WISE, NRR, WINE | LONDON BROKER RATINGS: UBS likes Pearson; Liberum cuts Naked Wine | Alliance |
| 04.07.2023 10:18 | GSK, HLN | PRESS: Advil owner Haleon to explore sale of nicotine gum business | Alliance |
| 03.07.2023 15:00 | GSK | Total Voting Rights | RNS |
| 28.06.2023 16:18 | GSK | GSK completes acquisition of chronic cough-focused Bellus Health | Alliance |
| 28.06.2023 15:43 | GSK | GSK completes acquisition of BELLUS Health | RNS |
| 27.06.2023 08:21 | GSK | GSK granted US FDA fast track for gonorrhoea vaccine | Alliance |
| 27.06.2023 07:00 | GSK | FDA Fast Track for Gonorrhoea Vaccine Candidate | RNS |
| 26.06.2023 08:38 | GSK | TOP NEWS: GSK hails approvals for drug therapies in Japan and Europe | Alliance |
| 26.06.2023 07:05 | GSK | Shingrix approved in Japan for adults 18 and over | RNS |
| 26.06.2023 07:00 | GSK | GSK daprodustat gains positive EMA CHMP opinion | RNS |
| 23.06.2023 17:25 | TRIG, CLI, GSK | DIRECTOR DEALINGS: GSK CFO buys shares worth GBP321,500 | Alliance |
| 23.06.2023 15:37 | GSK | Director/PDMR Shareholding | RNS |
| 23.06.2023 15:33 | GSK | Director/PDMR Shareholding | RNS |
| 23.06.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 23.06.2023 08:23 | HLN, GSK | TOP NEWS: GSK reaches settlement in California Zantac lawsuit | Alliance |
| 23.06.2023 07:00 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
| 22.06.2023 09:26 | GSK | GSK says Arexvy recommended in over 60s by US CDC committee | Alliance |
| 22.06.2023 07:00 | GSK | GSK’s Arexvy recommended by ACIP | RNS |
| 21.06.2023 08:20 | GSK | TOP NEWS: GSK reports positive data for RSV Arexvy vaccine | Alliance |
| 21.06.2023 07:00 | GSK | Season two data for GSK Arexvy RSV OA vaccine | RNS |
| 16.06.2023 07:42 | GSK | IN BRIEF: GSK says FDA extending review period for blood cancer drug | Alliance |
| 16.06.2023 07:00 | GSK | Extension of FDA review period for momelotinib | RNS |
| 12.06.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 09.06.2023 06:53 | GSK, AZN | AstraZeneca hails RSV drug nirsevimab recommendation by FDA committee | Alliance |
| 07.06.2023 07:59 | GSK | TOP NEWS: GSK's Arexvy is first EU-approved RSV jab for older adults | Alliance |
| 07.06.2023 07:00 | GSK | EU authorisation of GSK’s RSV vaccine Arexvy | RNS |
| 06.06.2023 08:34 | GSK | US FDA accepts GSK's licence application for cancer treatment Jemperli | Alliance |
| 06.06.2023 07:41 | HLN, GSK, ULVR | PRESS: Unilever starts search to replace Nils Andersen as chair | Alliance |
| 06.06.2023 07:00 | GSK | GSK receives US FDA file acceptance for Jemperli | RNS |
